{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T17:00:49Z","timestamp":1778346049042,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.cll.2012.04.003","type":"journal-article","created":{"date-parts":[[2012,6,20]],"date-time":"2012-06-20T05:54:34Z","timestamp":1340171674000},"page":"193-205","source":"Crossref","is-referenced-by-count":3,"title":["Screening for Cervical Cancer and Human Papilloma Virus"],"prefix":"10.1016","volume":"32","author":[{"given":"Kedar K.","family":"Deodhar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9828","key":"10.1016\/j.cll.2012.04.003_bib2","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(12)60358-4","article-title":"Cancer mortality in India: a nationally representative survey","volume":"379","author":"Dikshit","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cll.2012.04.003_bib3","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1517\/14656566.2011.596527","article-title":"Human papillomavirus: science and technologies for the elimination of cervical cancer","volume":"12","author":"Bosch","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.cll.2012.04.003_bib4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papilloma virus and cervical cancer","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cll.2012.04.003_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-66800-5_1","article-title":"Human papilloma viruses and their possible role in squamous cell carcinomas","volume":"78","author":"Zur Housen","year":"1977","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.cll.2012.04.003_bib6","series-title":"Blaustein's pathology of the female genital tract","first-page":"260","year":"2002"},{"key":"10.1016\/j.cll.2012.04.003_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/j.1460-2075.1989.tb03405.x","article-title":"Continued expression of HPV 16 E6 protein is required for maintenance of the transformed phenotype of cells cotransformed by HPV 16 plus EJ-ras","volume":"8","author":"Crook","year":"1989","journal-title":"Embo J"},{"key":"10.1016\/j.cll.2012.04.003_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0092-8674(88)90570-3","article-title":"The human papilloma virus type 16 E7 gene encodes the transactivation and transforming functions similar to those of adenovirus EIA","volume":"58","author":"Phelps","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.cll.2012.04.003_bib9","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.2537532","article-title":"The human papilloma virus 16 E7 oncoprotein is able to bind to the retinoblastoma gene product","volume":"243","author":"Dyson","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.cll.2012.04.003_bib10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0092-8674(93)90384-3","article-title":"The HPV 16 E6 and E6\u2013AP complex functions as a ubiquitin protein ligase in the ubiquitination of P53","volume":"75","author":"Scheffner","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.cll.2012.04.003_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cll.2012.04.003_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ijc.11691","article-title":"Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins","volume":"109","author":"Duensing","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cll.2012.04.003_bib13","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2217\/fmb.11.87","article-title":"Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts","volume":"6","author":"Sahasrabudhhe","year":"2011","journal-title":"Future Microbiol"},{"key":"10.1016\/j.cll.2012.04.003_bib14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","article-title":"Against which human papillomavirus types shall we vaccinate and screen?","volume":"111","author":"Munoz","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cll.2012.04.003_bib15","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cll.2012.04.003_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human paillpomavirus type distribution in invasive cervical cancer and high grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cll.2012.04.003_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ijc.2910600209","article-title":"Cancer risk in the renal transplant patients in the Nordic countries,1964\u20131986","volume":"60","author":"Birkeland","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cll.2012.04.003_bib18","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/jnci\/92.18.1500","article-title":"Human papilloma virus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome","volume":"92","author":"Frisch","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cll.2012.04.003_bib19","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(02)08151-5","article-title":"The role of parity and human papilloma virus in cervical cancer. The IARC multicentre case control study","volume":"359","author":"Munoz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cll.2012.04.003_bib20","first-page":"359","article-title":"Effect of oral contraceptives on risk on cervical cancer in women with papilloma virus infection: the IARC multicentric case control study","volume":"30","author":"Moreno","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cll.2012.04.003_bib21","first-page":"537","article-title":"History of tobacco use among Kentucky women diagnosed with invasive cervical cancer 1997\u20131998","volume":"99","author":"Wyatt","year":"2001","journal-title":"J Ky Med Assoc"},{"key":"10.1016\/j.cll.2012.04.003_bib22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1086\/338569","article-title":"Evidence of Chlamydia trachomatis as a human papilloma virus cofactor in the aetiology of the invasive cervical cancer in Brazil and the Philippines","volume":"185;","author":"Smith","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cll.2012.04.003_bib23","first-page":"5","article-title":"Trends in mortality from uterine cancer in relation to mass screening","volume":"21","author":"Christopherson","year":"1977","journal-title":"Acta Cytol"},{"key":"10.1016\/j.cll.2012.04.003_bib24","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(87)92695-X","article-title":"Trends in mortality from cervical cancer in the Nordic countries: association with organized screening programmes","volume":"1","author":"Laara","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.cll.2012.04.003_bib25","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0140-6736(78)92658-2","article-title":"Mortality from carcinoma of cervix uteri in Britain","volume":"2","author":"MacGregor","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.cll.2012.04.003_bib26","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the Papanicolaou test in screening for and follow up of cervical cytologic abnormalities: a systematic review","volume":"132","author":"Nanda","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cll.2012.04.003_bib27","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/jama.2009.1569","article-title":"Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial","volume":"302","author":"Siebers","year":"2009","journal-title":"Jama"},{"key":"10.1016\/j.cll.2012.04.003_bib28","series-title":"A practical manual on visual screening for cervical neoplasia","author":"Sankaranarayanan","year":"2003"},{"key":"10.1016\/j.cll.2012.04.003_bib29","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/ijc.20190","article-title":"Accuracy of visual screening for cervical neoplasia: results from an IARC multicentre study in India and Africa","volume":"110","author":"Sankaranarayanan","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cll.2012.04.003_bib30","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ijc.11245","article-title":"Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India","volume":"106","author":"Sankaranarayanan","year":"2003","journal-title":"Int J Cancer"},{"issue":"Suppl 2","key":"10.1016\/j.cll.2012.04.003_bib31","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ijgo.2005.01.009","article-title":"A critical assessment of screening methods for cervical neoplasia","volume":"89","author":"Sankaranarayanan","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.cll.2012.04.003_bib32","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10552-005-0296-4","article-title":"Screening test accuracy studies: how valid are our conclusions?","volume":"16","author":"Mahe","year":"2005","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.cll.2012.04.003_bib33","first-page":"14","article-title":"Accuracy of visual inspection with acetic acid for cervical cancer screening Int","volume":"113","author":"Sauvaget","year":"2011","journal-title":"J Gynecol Obstet"},{"key":"10.1016\/j.cll.2012.04.003_bib34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(07)61195-7","article-title":"Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster randomized trial","volume":"370","author":"Sankaranarayanan","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.cll.2012.04.003_bib35","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1056\/NEJMsa044278","article-title":"Cost effectiveness of cervical screening in five developing countries","volume":"353","author":"Goldie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cll.2012.04.003_bib36","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/ijc.21220","article-title":"Screening for cervical cancer in India: how much will it cost?","volume":"117","author":"Legood","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cll.2012.04.003_bib37","doi-asserted-by":"crossref","first-page":"A1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.cll.2012.04.003_bib38","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papilloma virus DNA test requirements for primary cervical cancer screening in women 30 yrs and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int J Cancer"},{"issue":"Suppl 10","key":"10.1016\/j.cll.2012.04.003_bib39","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","article-title":"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries","volume":"26","author":"Cuzick","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"10.1016\/j.cll.2012.04.003_bib40","article-title":"Clinical applications of HPV testing: a summary of meta-analyses","volume":"24","author":"Arbyn","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.cll.2012.04.003_bib41","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/jnci\/djn065","article-title":"Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test","volume":"100","author":"Ronco","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cll.2012.04.003_bib42","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2012.04.003_bib43","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1016\/j.ygyno.2007.07.021","article-title":"The New Technologies for Cervical Cancer Screening randomised controlled trial: an overview of results during the first phase of recruitment","volume":"107","author":"Ronco","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.cll.2012.04.003_bib44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2012.04.003_bib45","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S1386-6532(09)70013-7","article-title":"The next generation hybrid capture high risk HPV DNA assay on a fully automated platform","volume":"45","author":"Eder","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.cll.2012.04.003_bib46","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jcv.2011.01.016","article-title":"Analytical performance of CervistaR HPV 16\/18 genotyping test for cervical cytology samples","volume":"51","author":"Bartholomew","year":"2011","journal-title":"J Clin Virol"},{"key":"10.1016\/j.cll.2012.04.003_bib47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jviromet.2007.07.023","article-title":"Comparison of the AMLICOR human papilloma virus test and the hybrid capture 2 assay for detection of high risk human papilloma virus in women with abnormal PAP smear","volume":"147","author":"De Francesco","year":"2008","journal-title":"J Virol Methods"},{"key":"10.1016\/j.cll.2012.04.003_bib48","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1309\/AJCPZ5JY6FCVNMOT","article-title":"High risk human papilloma virus testing in women with ASC-US cytology: results from the ATHENA HPV study","volume":"135","author":"Stoler","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cll.2012.04.003_bib49","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S1470-2045(08)70210-9","article-title":"A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China","volume":"10;","author":"Qiao","year":"2008","journal-title":"Lancet Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2012.04.003_bib50","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S1386-6532(09)70009-5","article-title":"Clinical performance of the APTIMA HPV assay for the detection of high-risk HPV and high-grade cervical lesions","volume":"45","author":"Dockter","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.cll.2012.04.003_bib51","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/ijc.25726","article-title":"Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study","volume":"129","author":"Monsonego","year":"2011","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2012.04.003_bib52","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S1386-6532(09)70007-1","article-title":"Analytical characterization of the APTIMA HPV Assay","volume":"45","author":"Dockter","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.cll.2012.04.003_bib53","series-title":"Cervical cancer contemporary management","first-page":"66","article-title":"HPV vaccination in primary prevention of cervical cancer","author":"Sankaranarayanan","year":"2012"},{"key":"10.1016\/j.cll.2012.04.003_bib54","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jadohealth.2011.07.003","article-title":"The efficacy and safety of the quadrivalent human papillomavirus 6\/11\/16\/18 vaccine gardasil","volume":"49","author":"Haupt","year":"2011","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.cll.2012.04.003_bib55","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/jjco\/hyr173","article-title":"Safety and immunogenicity profile of human papillomavirus-16\/18 ASO4 adjuvant cervical cancer vaccine: a randomized controlled trial in healthy adolescent girls of Bangladesh","volume":"42","author":"Khatun","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.cll.2012.04.003_bib56","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/ijc.21220","article-title":"Screening for cervical cancer in India: how much will it cost?","volume":"117","author":"Legood","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cll.2012.04.003_bib57","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.mpdhp.2010.06.012","article-title":"Molecular markers of early cervical neoplasia","volume":"16","author":"Pinto","year":"2010","journal-title":"Diagn Histopathol"},{"key":"10.1016\/j.cll.2012.04.003_bib58","first-page":"150","article-title":"The roll of p16 (INK4A) immunostaining in the risk assessment of women with LSIL cytology: a prospective pragmatic study","volume":"32","author":"Valasoulis","year":"2011","journal-title":"Eur J Gynaecol Oncol"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271212000297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271212000297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T00:36:51Z","timestamp":1561855011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271212000297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0272271212000297"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2012.04.003","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}